Perspective Therapeutics ... (CATX)
AMEX: CATX
· Real-Time Price · USD
3.58
-0.32 (-8.21%)
At close: Aug 15, 2025, 3:59 PM
3.68
2.94%
After-hours: Aug 15, 2025, 06:29 PM EDT
Perspective Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 6.47M | -18.18M | -40.17M | -15.12M | -11.7M | -12.28M | -24.68M | -10.36M | -11.11M | -371K | -4.07M | -4.07M | -2.08M | -1.35M | -1.6M | -2.24M | -1.06M | -745K |
Depreciation & Amortization | 1.18M | 732K | 721K | 669K | 570K | 346K | 262K | 259K | 245K | 180K | 83K | 68K | 65K | 64K | 60K | 59K | 42K | 36K |
Stock-Based Compensation | 4.5M | 2.1M | 2.06M | 1.95M | 719K | 656K | 720K | 451K | 1.2M | 1.37M | 154K | 465K | 154K | 157K | 180K | 596K | 126K | 94K |
Other Working Capital | 468K | -3.64M | 1.45M | -663K | 542K | 26.09M | -364K | 1.01M | 45K | 26K | 221K | -25K | 753K | 173K | -343K | 131K | 145K | -186K |
Other Non-Cash Items | -17.67M | -852K | 24.32M | -485K | 10K | -266K | 4.86M | 68K | -12K | 42K | 2.19M | -33K | 22K | 18K | 19K | 18K | 21K | 16K |
Deferred Income Tax | -7.85M | n/a | -2.1M | n/a | n/a | n/a | 7.85M | 12K | 298K | -10.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K |
Change in Working Capital | -468K | -5.38M | -11.44M | 16.35M | 1.5M | 25.4M | 1.98M | -544K | 1.3M | -442K | -1.25M | 1.8M | -1.05M | -314K | 32K | -514K | -246K | -25K |
Operating Cash Flow | -13.83M | -21.58M | -26.61M | 3.37M | -8.9M | 13.85M | -9.01M | -10.11M | -8.07M | -9.72M | -2.89M | -1.76M | -2.89M | -1.42M | -1.31M | -2.08M | -1.12M | -621K |
Capital Expenditures | -4.81M | -4.66M | -14.61M | -29.71M | -1.01M | -9.07M | -89K | -227K | -555K | -201K | -105K | -90K | -105K | -26K | -81K | -54K | -115K | -93K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -67.09M | -22.6M | -164.78M | n/a | -40.51M | -38.23M | n/a | n/a | n/a | -25.46M | n/a | -35.08M | n/a | -35.08M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 71.52M | 21.7M | 40.51M | n/a | 38.23M | n/a | n/a | n/a | n/a | 22.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -27K | -9K | 287K | -24K | n/a | n/a | n/a | n/a | -18K | n/a | -18K | n/a | -18K | 35.08M | n/a | n/a | -23K | -6K |
Investing Cash Flow | -412K | -5.57M | -138.6M | -29.74M | -3.29M | -47.3M | -89K | -227K | -573K | 25.26M | -123K | -35.17M | -123K | -26K | -81K | -54K | -138K | -99K |
Debt Repayment | n/a | -13K | -12K | -16K | -8K | -12K | -12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.24M | n/a | 12.25M | 644K | -112.94M | 113.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 9.24M | 9.97M | 345K | 628K | 122.08M | 166.33M | 352K | 1K | 512K | -80K | n/a | 28K | n/a | 28K | 56K | n/a | 243K | 55.98M |
Net Cash Flow | 19.43M | -17.17M | -164.86M | -25.74M | 109.89M | 142.3M | -8.74M | -10.34M | -8.13M | 15.46M | 36.9M | -36.9M | -3.01M | -1.45M | -1.34M | -2.14M | -1.01M | 55.26M |
Free Cash Flow | -18.64M | -26.24M | -41.22M | -26.35M | -9.92M | 4.78M | -9.1M | -10.34M | -8.63M | -9.92M | -3M | -1.85M | -3M | -1.45M | -1.39M | -2.14M | -1.23M | -714K |